Feb 25, 2019 - Chemed's (CHE) Q4 revenues grow across key segments.
Feb 22, 2019 - Abbott Laboratories (ABT) Files 10-K for the Fiscal Year Ended on December 31, 2018, Stocks: ABT, release date:Feb 22, 2019
Feb 22, 2019 - Quest Diagnostics' (DGX) progress in prescription drug monitoring, QuantiFERON and non-invasive prenatal screening are part of its recent major developments.
Feb 22, 2019 - DaVita (DVA) steadily expands in international markets. Moreover, the company has witnessed Dialysis services in the United States lately.
Feb 22, 2019 - NuVasive (NUVA) reports growth in revenues across all key operating segments in the fourth quarter of 2018.
Feb 20, 2019 - CVS Health's (CVS) recently introduced Health Care Benefits segment following the Aetna acquisition holds immense promise.
Feb 20, 2019 - The regulatory go-ahead for the Ion platform is likely to provide Intuitive Surgical (ISRG) a competitive edge in the minimally-invasive-care space.
Feb 19, 2019 - Surmodics' (SRDX) solid efforts to improve its research and development stature are likely to prove beneficial in the quarters ahead.
Feb 14, 2019 - Johnson & Johnson (JNJ) entered into a definitive agreement to acquire Auris Health, Inc., a developer of robotic technologies focused on lung cancer, for approximately $3.4 billion in cash.
Feb 13, 2019 - Boston Scientific's (BSX) closure of Millipede acquisition and its buyout agreement with BTG plc are major developments for the company.